Journal of Agricultural and Food Chemistry
Article
(GenBank CUA76508.1) was generated with the crystal
structure of cow’s brain β-tubulin (PDB ID 1Z2Bb) as the
template. A sequence alignment showed their sequence identity
value was 86%. Combretastatin A-4 and carbendazim were used
to identify the receptor binding pockets and to analyze the
binding characteristics with a blind docking calculation in this
study. The colchicine binding site of tubulin has been validated
as the binding pocket of combretastatin A-4 (Figure 3) between
two adjacent subunits of tubulin.16 Thus, the colchicine binding
site was used for the docking simulation of combretastatin
A-4 and derivatives. Hydrogen-bonding interactions show that
combretastatin A-4 is bound to Val236 and Asn256 of subunit
A of the β-tubulin model. This suggested a hydrogen-bonding
interaction between the hydroxyl group of combretastatin A-4
and Val236 is critical for full biological activity, which explains
why the biological activity was lost if the hydroxyl group was
replaced by a nitro or disodium phosphate group. Figure 2
shows that the carbendazim binding site is different from that
of combretastatin A-4. Carbendazim has interactions only
with one subunit of β-tubulin. Qiu et al.17 demonstrated the
possible binding pocket for carbendazim on the β2-tubulin in
Gibberella zeae was formed with residues Tyr50, Phe167,
Glu198, Phe200, and Arg241. Sequence alignment showed
those above residues are conserved (Figure 3). The carbendazim
binding pocket of R. solani β-tubulin was also formed with those
residues. In addition, His6 and Trp21 formed two hydrogen
bonds with carbendazim in our model, explaining why muta-
tions at the codons 6 gene were responsible for resistance to
carbendazim.7
It is obvious that the binding sites of combretastatin A-4
and carbendazim on fungal tubulin are totally different, which
suggested that combretastatin A-4 and derivatives can be the
useful for controlling carbendazim-resistant plant diseases.
Antifungal Effects on Resistant Strains. Two carbenda-
zim-resistant strains (Fusarium oxysporum Schl. f. sp. vasinfectum
(Atk.) Snyd. & Hans and Sclerotinia sclerotiorum (Lib.) de Bary)
were used to test the antifungal effects of combretastatin A-4
and derivatives on the resistant fungi. The results demonstrated
that combretastatin A-4 and 2 have appreciable inhibitory ability
to the resistant fungi, compared with carbendazim (Table 2).
On testing with F. oxysporum, the inhibition by combretastatin
A-4 was 2.5-fold greater than that of carbendazim. Combretas-
tatin A-4 and 2 have nearly 5- and 4-fold more antifungal effects
than carbendazim against S. sclerotiorum. This result showed
that the binding sites of combretastatin A-4 and derivatives
are different from that of carbendazim, which suggested that
combretastatin A-4 is a good lead compound for new fungicide
discovery that can be used for the control of carbendazim-
resistant fungi.
AUTHOR INFORMATION
■
Corresponding Authors
*(Z.-P.K.) Phone: +86 136 71951027. Fax: +86 21 60877220.
*(F.-H.W.) Phone: +86 21 60877220. Fax: +86 21 60877220.
Funding
This work was supported by grants from the National Natural
Science Foundation of China (No. 21402122 and 21472126).
It was also supported by the Natural Science Foundation of
Shanghai (No. 14ZR1440600) and the Innovation Program of
Shanghai Municipal Education Commission (No. 14YZ148).
Notes
The authors declare no competing financial interest.
REFERENCES
■
(1) Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.;
Kendall, D. G. Isolation and structure of the strong cell growth and
tubulin inhibitor combretastatin A-4. Experientia 1989, 45, 209−211.
(2) Salehi, M.; Ostad, S. N.; Riazi, G. H.; Assadieskandar, A.; Shavi,
T. C.; Shafiee, A.; Amini, M. Synthsis, cytotoxic evaluation, and
molecular docking study of 4,5-diaryl-thiazole-2-thione analogs of
combretastatin A-4 as microtubule-binding agents. Med. Chem. Res.
2014, 23, 1465−1473.
(3) Hamze, A.; Rasolofonjatovo, E.; Provot, O.; Mousset, C.; Veau,
D.; Rodrigo, J.; Bignon, J.; Liu, J. M.; Bakala, J. W.; Thoret, S.; Dubois,
J.; Brion, J. D.; Alami, M. B-Ring-Modified isoCombretastatin A-4
analogues endowed with interesting anticancer activities. ChemMed-
Chem 2011, 6, 2179−2191.
(4) Qin, Y. J.; Li, Y. J.; Jiang, A. Q.; Yang, M. R.; Zhu, Q. Z.; Dong,
H.; Zhu, H. L. Design, synthesis and biological evaluation of novel
pyrazoline-containing derivatives as potential tubulin assembling
inhibitiors. Eur. J. Med. Chem. 2015, 94, 447−457.
(5) Verhey, K. J.; Gaertig, J. The tubulin code. Cell Cycle 2007, 6,
2152−2160.
(6) Bollen, G. J.; Scholten, G. Acquired resistance to benomyl and
some other systemic fungicides in a strain of Bostryis cinerea in
cyclamen. Neth. J. Plant Pathol. 1971, 77, 83−90.
(7) Qiu, J. B.; Huang, T. T.; Xu, J. Q.; Bi, C. W.; Chen, C. J.; Zhou,
M. G. β-Tubulins in Gibberella zeae: their characterization and
contribution to carbendazim resistance. Pest Manage. Sci. 2012, 68,
1191−1198.
(8) Shen, W. P.; Diao, Y. J.; Jin, H. M.; Wang, J. P.; Wang, J. G.
Synthesis of combretastatin A-4 supported by polymer. Chinese Patent
CN 1704393A, 2005.
(9) Zhao, L.; Zhou, J. J.; Huang, X. Y.; Cheng, L. P.; Pang, W.; Kai, Z.
P.; Wu, F. H. Design, synthesis and anti-proliferative effects in tumor
cells of new combretastatin A-4 analogs. Chin. Chem. Lett. 2015, 26,
993−999.
(10) Shi, J.; Blundell, T. L.; Mizuguchi, K. FUGUE: sequence-
structure homology recognition using environment-specific substitu-
tion tables and structure-dependent gap penalties. J. Mol. Biol. 2001,
310, 243−257.
(11) Sutcliffe, M. J.; Haneef, I.; Carney, D.; Blundell, T. L.
Knowledge based modelling of homologous proteins, part I: three-
dimensional frameworks derived from the simultaneous superposition
of multiple structures. Protein Eng., Des. Sel. 1987, 1, 377−384.
(12) Halgren, T. A. MMFF VI. MMFF94s option for energy
minimization stydies. J. Comput. Chem. 1999, 20, 720−729.
(13) Head, J. D.; Zerner, M. C. A Broyden-Fletcher-Goldfarb-Shanno
optimization procedure for molecular geometries. Chem. Phys. Lett.
1985, 122, 264−270.
(14) Kai, Z. P.; Ling, Y.; Liu, W. J.; Zhao, F.; Yang, X. L. The study of
solution conformation of allatostatins by 2-D NMR and molecular
modeling. Biochim. Biophys. Acta, Proteins Proteomics 2006, 1764, 70−
75.
In conclusion, combretastatin A-4 was first isolated from
the African willow tree, and the double bond in part A of
combretastatin A-4 was hydrogenated; the hydroxyl group in
part B was replaced by amino, nitro, or disodium phosphate
group, and the methoxy group in part C was replaced by an
ethoxy group to afford 12 combretastatin A-4 derivatives,
respectively. Combretastatin A-4 and its derivatives were
identified as new potential fungicides targeting fungal tubulin.
Because their binding site is entirely different from that of
carbendazim, they are possibly useful for fungal resistance
management. The results of antifungal assays on resistant
strains confirmed our hypothesis.
750
J. Agric. Food Chem. 2016, 64, 746−751